This event offers practical advice, case studies, and a deep dive into the Abbreviated New Drug Application (ANDA) review process. Presentations will focus on various aspects from pre-ANDA, drug development, post-marketing and global generic drug affairs program support for the generic drug program.
The agenda may be updated as changes are made. The link above is to the latest version, Version 8, updated on April 24, 2021. | The speaker biographies document provides detailed information of each of the Forum speakers. |
Session Recordings:
Day One:
Day Two:
Questions?
Please refer the FAQs page on this website. If you are not able to find your answer there, please email us at info@sbiaevents.com.
More Information
If you have questions regarding the content of the event or other CDER-specific information, please: